Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoBRIM-B: Cobimetinib and Vemurafenib for Melanoma Brain Metastases
NCT02230306Phase 2Terminated
- Start
- Feb 2015
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
A Phase 2 trial of cobimetinib in melanoma. Started Feb 2015; status: terminated.
02
Drugs
cobimetinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02230306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230306.